Bulletin
Investor Alert

March 13, 2020, 12:04 p.m. EDT

Ulta Beauty: Key Takeaways from Its Mixed Q4 Results

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Ulta Beauty Inc. (ULTA)

or Cancel Already have a watchlist? Log In

Mar 13, 2020 (Market Realist via COMTEX) -- Ulta Beauty /zigman2/quotes/210513442/composite ULTA +0.29% stock fell 10.3% on Thursday as the US stock market crashed due to rising concerns related to the coronavirus. Ulta Beauty CEO Mary Dillon issued a statement yesterday. She revealed the steps that the company has taken due to the outbreak. She said that Ulta Beauty has taken the required precautions. The company is temporarily suspending its skin, makeup, brow, lash and waxing services. Investors are concerned about whether the coronavirus might have a significant impact on the company's business.

Ulta Beauty stock fell 1.8% in the after-hours trading on Thursday in reaction to the company's mixed results for the fourth quarter of fiscal 2019. The company's earnings beat Wall Street's expectations, while the net sales lagged the predictions.

As of Thursday, Ulta Beauty stock has fallen 21.6% year-to-date. However, the stock has risen 6.9% as of 10:16 AM ET today.

Ulta Beauty's Q4 earnings

Ulta Beauty's sales rose 8.5% YoY (year-over-year) to $2.31 billion. Analysts expected sales of $2.32 billion for the holiday sales quarter. The comparable sales growth of 4% in the fourth quarter of fiscal 2019 reflected a slowdown compared to 9.4% in the fourth quarter of fiscal 2018. However, the comparable sales exceeded analysts' forecast of 3.38%.

The slowdown in the US make-up category, in prestige and mass channels, continued to have a negative impact on the company's sales. The skincare category delivered strong results in the quarter. Also, the company's e-commerce sales grew by double digits. The demand for celebrity beauty brands like Kylie Jenner's "Kylie Cosmetics" helped the company offset the weakness in certain established prestige brands to some extent.

Ulta Beauty's fourth-quarter EPS grew 7.8% YoY to $3.89 and beat analysts' forecast of $3.73. The company's EPS gained from higher sales and a $0.06 benefit from higher federal income tax credits. However, a lower operating margin had a negative impact on the bottom line.

The fourth-quarter gross margin expanded by 10 basis points YoY to 35.0% due to higher merchandise margins. However, the company's operating margin fell by about 70 basis points YoY to 12.5%. Growth investments, higher marketing expenses, and increased payroll expenses impacted the operating margin.

Weak outlook

Ulta Beauty expects its total sales growth to be 7.0%-8.0%. The company expects its comparable sales growth to be 3%-4% in fiscal 2020. The estimated growth rates don't take the coronavirus into account. Notably, the estimates are still lower than the fiscal 2019 growth rates. In fiscal 2019, the company's net sales grew 10.1% to $7.40 billion, while comparable sales grew 5%.

The company expects its fiscal 2020 EPS to be $12.55-$12.75 compared to $12.15 in fiscal 2019. Analysts expected an EPS of $13.06 for fiscal 2020. Ulta Beauty expects challenges in the makeup category to be a drag on its business. The coronavirus will likely have a negative impact on the beauty industry and retail sector.

Analysts cut their target price for Ulta Beauty stock

Several analysts lowered their target price for Ulta Beauty stock following the mixed results and weak outlook.

  • Piper Sandler lowered its target price to $215 from $235.

  • Oppenheimer lowered its target price to $275 from $310.

  • J.P. Morgan lowered its target price to $290 from $326.

  • Cowen and Company lowered its target price to $265 from $300.

  • Evercore ISI lowered its target price to $270 from $375.

/zigman2/quotes/210513442/composite
US : U.S.: Nasdaq
$ 244.01
+0.70 +0.29%
Volume: 2.63M
May 29, 2020 4:00p
P/E Ratio
32.50
Dividend Yield
N/A
Market Cap
$13.74 billion
Rev. per Employee
$193,562
loading...
1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.